Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Go back to Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial| (NASDAQ: ALLO) | Delayed: 1.67 -0.04 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.73 | 52 Week Low | $ | |||
| Day High | $1.74 | P/E | N/A | |||
| Day Low | $1.65 | EPS | $ | |||
| Volume | 5,965,949 | |||||
